InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,477.90
(
0.16%
)
US TECH 100
19,150.80
(
-0.13%
)
Dow Jones
39,127.80
(
0.04%
)
Brent Oil
84.44
(
0.30%
)
Bitcoin
60,832.19
(
-1.58%
)
Post# of 252380
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

poorgradstudent

Send PM Follow Ignore
Followers 73
Posts 3426
Boards Moderated 1
Alias Born 04/28/2004

poorgradstudent

Re: iwfal post# 195254

Thursday, 09/24/2015 1:37:15 PM

Thursday, September 24, 2015 1:37:15 PM

Post# of 252380
Turing etc...

Question: if in 4 years it is apparent that substantive work has happened on new drugs would this lessen your disapproval substantially?

And in the more FWIW category, I think he really will spend money on development. Within family of other biotechs with revenue. He was in Retrophin, for instance.



Sure, why wouldn't I?

But has he ever spent money on R&D in a meaningful manner?

Have any of his prior companies ever completed a meaningful clinical trial? Published any papers? Developed a next-generation compound for a disease of choice?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up